Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

BACKGROUND: Characterization of the mesenchymal stromal cell (MSC) safety profile is important as this novel therapy continues to be evaluated in clinical trials for various inflammatory conditions. Due to an increase in published randomized controlled trials (RCTs) from 2012–2019, we performed an u...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EClinicalMedicine
Main Authors: Thompson, Mary, Mei, Shirley H.J., Wolfe, Dianna, Champagne, Josée, Fergusson, Dean, Stewart, Duncan J., Sullivan, Katrina J., Doxtator, Emily, Lalu, Manoj, English, Shane W., Granton, John, Hutton, Brian, Marshall, John, Maybee, Alies, Walley, Keith R., Santos, Claudia Dos, Winston, Brent, McIntyre, Lauralyn
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Research paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6970160/
https://ncbi.nlm.nih.gov/pubmed/31989101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.100249
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares